Home › Asset managers › Compare 2024-2025 › Fidelity vs Lincoln Financial
Fidelity 2024-2025 · Lincoln Financial 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 74,342 | 65,321 | 2,324 | 6,697 | 96.6% | 93.2% |
| Board proposals | 60,945 | 53,132 | 2,069 | 5,744 | 96.3% | 92.7% |
| E&S shareholder proposals | 270 | 135 | 4 | 131 | 97.1% | 85.8% |
| Other items | 13,127 | 12,054 | 251 | 822 | 98.0% | 95.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
7,813 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Fidelity | Lincoln Financial |
|---|---|---|---|---|---|---|
| COMPANY FOR COOPERATIVE INSURANCE | May 27, 2025 | Authorize Share Repurchase Program Up to 199,862 Shares to be Allocated for Employees Stock Incentive program and Authorize Board to Execute All Related Matters Capital Structure |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| COMPASS INC. | May 22, 2025 | Election of Class I Directors: Frank Martell Director Elections |
Board | For | FOR 42 funds |
AGAINST 2 funds |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Director Nominees: Ann Manix Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| COMTECH TELECOMMUNICATIONS CORP. | January 13, 2025 | Approval, on an advisory basis, of the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| COMTECH TELECOMMUNICATIONS CORP. | January 13, 2025 | Election of Directors: Lawrence J. Waldman Director Elections |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| COMTECH TELECOMMUNICATIONS CORP. | January 13, 2025 | Election of Directors: Mark R. Quinlan Director Elections |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| COMTECH TELECOMMUNICATIONS CORP. | January 13, 2025 | Election of Directors: Wendi B. Carpenter Director Elections |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| CONCRETE PUMPING HOLDINGS INC. | April 22, 2025 | To elect the four Class I Director nominees: David G. Hall Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 2 funds |
| CONCRETE PUMPING HOLDINGS INC. | April 22, 2025 | To elect the four Class I Director nominees: Heather L. Faust Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 2 funds |
| CONDUIT PHARMACEUTICALS INC. | December 18, 2024 | Election of Directors: Chele Chiavacci Farley Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 1 fund |
| CONDUIT PHARMACEUTICALS INC. | December 18, 2024 | Election of Directors: David Tapolczay Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 1 fund |
| CONDUIT PHARMACEUTICALS INC. | December 18, 2024 | Election of Directors: Faith L. Charles Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 1 fund |
| CONDUIT PHARMACEUTICALS INC. | December 18, 2024 | Election of Directors: Freda Lewis-Hall Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 1 fund |
| CONSTELLIUM SE | May 15, 2025 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Item 15 Capital Structure |
Board | For | FOR 14 funds |
AGAINST 2 funds |
| CONSUMER PORTFOLIO SERVICES INC. | November 12, 2024 | Election of Directors: Brian J. Rayhill Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| CONSUMER PORTFOLIO SERVICES INC. | November 12, 2024 | Election of Directors: Daniel S. Wood Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| CONSUMER PORTFOLIO SERVICES INC. | November 12, 2024 | Election of Directors: William B. Roberts Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| CONTAINER STORE GROUP INC. | August 28, 2024 | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| CONTANGO ORE INC. | June 10, 2025 | Election of Directors: Brad Juneau Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| CONTANGO ORE INC. | June 10, 2025 | Election of Directors: Darwin Green Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| CONTANGO ORE INC. | June 10, 2025 | Election of Directors: Richard A. Shortz Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| CONVATEC GROUP PLC | May 22, 2025 | Approve Omnibus Incentive Plan Compensation |
Board | For | FOR 19 funds |
AGAINST 1 fund |
| CORE MOLDING TECHNOLOGIES INC. | May 15, 2025 | Election of Directors: Sandra L. Kowaleski Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 1 fund |
| CORECARD CORP. | May 29, 2025 | Approval of the CoreCard Corporation 2025 Employee Stock Incentive Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| CORECARD CORP. | May 29, 2025 | Election of Two Directors. Nominees: Kathryn Petralia Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| CORECARD CORP. | May 29, 2025 | Election of Two Directors. Nominees: Philip H. Moise Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| CORSAIR GAMING INC. | June 10, 2025 | Election of three Class II Directors to serve until the 2028 annual meeting of stockholders or until their successors are elected: Anup Bagaria Director Elections |
Board | For | FOR 14 funds |
WITHHOLD 3 funds |
| COUCHBASE INC. | May 29, 2025 | Election of Class I Directors: Lynn M. Christensen Director Elections |
Board | For | FOR 13 funds |
WITHHOLD 2 funds |
| CRANSWICK PLC | July 29, 2024 | Approve Remuneration Policy Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| CRAWFORD & CO. | May 8, 2025 | Proposal to elect the nine (9) nominees listed below as Directors: J. C. Crawford Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 2 funds |
| CRAWFORD & CO. | May 8, 2025 | Proposal to elect the nine (9) nominees listed below as Directors: J. C. Crawford, Jr. Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 2 funds |
| CRAWFORD & CO. | May 8, 2025 | Proposal to elect the nine (9) nominees listed below as Directors: L. G. Hannusch Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 2 funds |
| CREDITO EMILIANO SPA | April 30, 2025 | Approve Second Section of the Remuneration Report Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.c Re-election of Maria Fardis, Ph.D. Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.e Re-election of Simeon J. George, M.D. Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.g Re-election of Katherine A. High, M.D. Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.h Re-election of Sandesh Mahatme, LL.M. Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.i Re-election of Christian Rommel, Ph.D. Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 6.b Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CRONOS GROUP INC | July 19, 2024 | ADOPTION OF AN ADVISORY (NON-BINDING) RESOLUTION TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT DATED APRIL 26, 2024 Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Elizabeth Seegar Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: James Rudyk Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Jason Adler Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Michael Gorenstein Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Michael Gorenstein Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CROWDSTRIKE HOLDINGS INC. | June 18, 2025 | To elect CrowdStrike's nominees Cary J. Davis, George Kurtz and Laura J. Schumacher to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Cary J. Davis Director Elections |
Board | For | FOR 37 funds |
WITHHOLD 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | April 15, 2025 | Approve Use of Idle Raised Funds and Own Funds for Cash Management Extraordinary Transactions |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Andrew W. Hobson Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Brian G. Kushner Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Deborah A. Farrington Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Joan Hogan Gillman Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Mary G. Berner Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Thomas H. Castro Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Proposal to approve, on an advisory basis, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| CUSTOM TRU | June 12, 2025 | To elect each of the four Class C directors to serve until the 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified: Fred Ross Director Elections |
Board | Not determined | FOR 12 funds |
WITHHOLD 2 funds |
| CUTERA INC. | July 15, 2024 | Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 2,395,275 shares. Compensation |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Approval of the amendment of outstanding stock options to reduce the exercise price per share to the closing price on the date of the Annual Meeting. Compensation |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Election of Directors: Jeryl Hilleman Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Election of Directors: Keith Sullivan Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Election of Directors: Kevin Cameron Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CVS GROUP PLC | November 20, 2024 | Approve Remuneration Report Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| D'AMICO INTERNATIONAL SHIPPING SA | April 29, 2025 | Approve DIS 2025-2027 Medium-Long Term Variable Incentive Plan Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends Capital Structure |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DANIELI & C. OFFICINE MECCANICHE SPA | October 25, 2024 | Authorize Share Repurchase Program and Reissuance of Repurchased Shares Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Election of Directors: John P. Amboian Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 1 fund |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | December 31, 2024 | Approve Financing Proposal of Datang International as the Parent Company for the Year of 2025 Capital Structure |
Board | For | AGAINST 5 funds |
FOR 1 fund |
← Previous Page 5 of 79 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.